SUSAN G. KOMEN® APPOINTS FIVE NEW MEMBERS TO BOARD OF DIRECTORS

March 30, 2022
 

Susan G. Komen®, the world’s leading breast cancer organization welcomes five industry leaders from healthcare, finance and technology to serve on the organization’s Board of Directors. The incoming members join an elite group of 13 executives to help govern and advise the world’s leading non-profit breast cancer organization in its mission to end breast cancer.

The new members include:

BJ Schaknowski, CEO of symplr. Julie Gruber, Executive Vice President and Chief Legal Officer of Gap, Inc. Kristen Maple Racich, Partner and Chief Impact Officer for Lord Abbett. Robyn Shepherd, Partner and the Head of Corporate Engagement at Bridgewater Associates. Lydia The, Partner in McKinsey's Life Sciences Practice.


BJ Schaknowski, CEO of symplr, a leading healthcare operations software and services company. Schaknowski is a seasoned software industry executive with over 20 years of experience in leadership roles across a wide variety of operating functions. He earned a BA in Communications from the State University of New York at Geneseo and his MBA at the University of Georgia – Terry College of Business. He also served in the United States Marine Corps infantry as an enlisted reservist for 8 years.

Read the full press release here.